Product Information

PERAMPANEL 4 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $15.4239 per EA under NDC 72205022230. Its NADAC has been published 30 times since Jan 28, 2026.

FDA first approved this application on Nov 25, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERAMPANEL 4 MG TABLET

Perampanel
$15.4239per EA
DEA Schedule CIII

Strength

4 mg/1

NDC

72205022230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERAMPANEL

Approval Type

Generic (ANDA)

FDA Application

ANDA218178

FDA Approved

11/25/2025

TE Code

AB

On Market Since

11/25/2025

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for PERAMPANEL 4 MG TABLET has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.

Current price$15.4239 per EA
All-time high$31.9257 (Feb 11, 2026)
All-time low$15.4239 (Aug 19, 2026)
52-week high$31.9257
52-week low$15.4239
Median price$20.5522
Average price$21.9433
Largest weekly change-19.8% (Apr 22, 2026)
Weeks tracked30
Tracking sinceJan 28, 2026

Price History

1W

-4.2%

1M

-4.2%

3M

-11.4%

6M

-48.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-51.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PERAMPANEL 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 4 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $15.4239 per EA (NDC 72205022230), effective Aug 19, 2026.

How has the price of PERAMPANEL 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERAMPANEL 4 MG TABLET has declined 51.7%. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for PERAMPANEL 4 MG TABLET?

Since Jan 28, 2026, the NADAC for PERAMPANEL 4 MG TABLET has ranged from a low of $15.4239 (Aug 19, 2026) to a high of $31.9257 (Feb 11, 2026), with a median of $20.5522 per EA.

Are there cheaper alternatives to PERAMPANEL 4 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 4 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERAMPANEL 4 MG TABLET?

PERAMPANEL 4 MG TABLET (NDC 72205022230) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.